With all the above results, we identified a molecular sub-cluster of colon cancer cells which was particularly sensitive to chemotherapy, BRAF inhibitors and PI3K-mTOR inhibitors treatment. The gene discussed is PIK3CA; the disease is malignant colon neoplasm.